目录
- Stimuli-responsive nanocarriers for therapeutic applications in cancer
- Recent progress of nanotechnology-based theranostic systems in cancer treatments
- Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
- Gold-based nanomaterials for the treatment of brain cancer
- Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
- The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma
- Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma
- Circular RNAs: new biomarkers of chemoresistance in cancer
- Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies
- Biomaterial-based platforms for cancer stem cell enrichment and study
- BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
- sLex expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator
- Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
- Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
- A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
- Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis
- L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma
- The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
- CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner
- LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
- A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
- Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer